Data source details

Jack Church

As new concepts for drug discovery in the post-genomic age continue to be introduced, synthetic organic chemistry continues to be pivotal to the success of these programs. Adesis, Inc. is a contract research organization (CRO) specializing in organic synthesis.

We specialize in the synthesis of milligrams to kilogram quantities including:

  • Early stage proof-of-concept (POP) projects to validate biological hypotheses
  • Validation of screening hits for exploratory medicinal chemistry (hit-to-lead)
  • In-depth structure-activity relationship (SAR) studies
  • Intermediates for expediting med chemistry SAR campaigns
  • Drug candidates for in vivo studies
  • Reference agents for bioprofiling
  • Reference metabolites
  • Building blocks for combinatorial chemistry
  • Key intermediates for pharmaceuticals
  • Key intermediates for biomaterial and biosensor applications


Adesis Inc.  

+302 323 6305  


27 McCullough Drive  

New Castle  



United States 

Substance Vendors







Feedback Form